Heat shock proteins in atrial fibrillation: from bench to bedside
- PMID: 40786071
- PMCID: PMC12331728
- DOI: 10.3389/fphys.2025.1644898
Heat shock proteins in atrial fibrillation: from bench to bedside
Abstract
Atrial fibrillation (AF) is the most common age-related arrhythmia in clinic, affecting millions of people around the world, and is closely related to heart failure, ischemic stroke and other diseases. In addition, AF is progressive in nature and represents a significant global health burden. However, the current treatment plans are mainly symptomatic, the efficacy in preventing atrial fibrillation is limited. Hence, there is a pressing need for etiology-specific AF treatments. It is widely acknowledged that the atrial electrical and structural remodeling constitutes the pathological basis of atrial fibrillation. Evidence indicates that heat shock proteins (HSPs) could have a protective effect against AF. HSPs are a diverse family of molecular chaperones that safeguard cells against various stressors. They play a crucial role in mitigating oxidative stress, inflammation, and apoptosis, thereby helping to prevent structural and electrical remodeling in cardiomyocytes. Moreover, HSPs safeguard proteostasis via prevention of toxic protein aggregation by binding to (partially) unfolded proteins. As pivotal inhibitors of AF onset and progression, HSPs represent both a promising therapeutic target and potential biomarkers for staging AF and predicting post-treatment recurrence, as evidenced by recent studies. In this review, we explore the mechanisms of HSP in AF to pave the way for the development of targeted therapies for this prevalent arrhythmia disease.
Keywords: atrial fibrillation; heat shock proteins; inducer; inflammation; oxidative stress; proteostasis.
Copyright © 2025 Zhang, Wang, Nie, Feng, Zhang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Left atrial appendage occlusion in atrial fibrillation: shaping the future of stroke prevention.Future Cardiol. 2025 May;21(6):391-404. doi: 10.1080/14796678.2025.2484964. Epub 2025 Mar 26. Future Cardiol. 2025. PMID: 40136040 Review.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340. Health Technol Assess. 2008. PMID: 19036232
-
Systematic screening for the detection of atrial fibrillation.Cochrane Database Syst Rev. 2016 Jun 3;2016(6):CD009586. doi: 10.1002/14651858.CD009586.pub3. Cochrane Database Syst Rev. 2016. PMID: 27258214 Free PMC article.
-
Dronedarone for the treatment of atrial fibrillation and atrial flutter.Health Technol Assess. 2010 Oct;14(Suppl. 2):55-62. doi: 10.3310/hta14suppl2/08. Health Technol Assess. 2010. PMID: 21047492
References
-
- Aguiar C. M., Gawdat K., Legere S., Marshall J., Hassan A., Kienesberger P. C., et al. (2019). Fibrosis independent atrial fibrillation in older patients is driven by substrate leukocyte infiltration: diagnostic and prognostic implications to patients undergoing cardiac surgery. J. Transl. Med. 17 (1), 413. 10.1186/s12967-019-02162-5 - DOI - PMC - PubMed
-
- Attia A., Muthukumarasamy K. M., Al-U'Datt D. G. F., Hiram R. (2025). Relevance of targeting oxidative stress, inflammatory, and pro-resolution mechanisms in the prevention and management of postoperative atrial fibrillation. Antioxidants Basel, Switz. 14 (4), 414. 10.3390/antiox14040414 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials